Combining survival and toxicity effect sizes from clinical trials into an interpretable, quality-adjusted survival effect size estimate of treatment efficacy.
- Citation:
- J Clin Oncol vol 32 (15_suppl) 6630
- Meeting Instance:
- ASCO 2014
- Year:
- 2014
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 2334
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Jeff A. Sloan
- Authors:
- Jeff A. Sloan Brittny Major Paul J. Novotny Axel Grothey Randolph Marks Daniel J. Sargent Amylou C. Dueck
- Networks:
- Study
- NCCTG-89-20-52
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: